Navigating a Market of High Demand and Unique Regulations
For nephrology practice owners in Oregon, the decision to sell involves more than finding a buyer. You are navigating Oregon’s unique market, which is shaped by a growing demand for services and some of the nation’s strictest healthcare regulations. This guide provides a clear overview of the current landscape, from valuation to post-sale planning, helping you understand the path to a successful transition.
Not sure if selling is right for you? Our advisors can help you understand your options without any pressure.
Market Overview
The market for nephrology practices is strong, driven by powerful national trends that directly benefit owners in Oregon. Buyers see significant opportunity, and your practice is likely more valuable than you think. The current environment is defined by three key factors.
- Surging Patient Need. The demand for kidney care is steadily increasing. This underlying growth provides a stable foundation for your practice’s future revenue, a fact that is very attractive to potential buyers.
- A Shortage of Specialists. The country is facing a projected 21% shortage of nephrologists by 2037. This scarcity makes your established practice, with its patient base and referral network, a highly sought-after asset.
- A Shift in Care Models. The move toward value-based care, like the Kidney Care Choices (KCC) model, is changing how practices operate. Buyers are actively looking for practices that have adapted to or can easily transition to these new, efficiency-focused payment systems.
Key Considerations
While market demand is high, selling in Oregon requires navigating a significant state-specific rule: the Corporate Practice of Medicine (CPOM) doctrine. This law is one of the strictest in the country. It mandates that at least 51% of a medical practice must be owned by Oregon-licensed medical providers. This rule directly impacts the types of buyers who can acquire your practice and how a sale must be structured, particularly for corporate or private equity groups.
These regulations make experience with Oregon-specific transactions critical. The wrong deal structure can create legal challenges for a buyer down the road, which is a risk they will not take. Understanding how to structure a sale in compliance with CPOM is the first step to a successful closing. It influences everything from valuation to the types of offers you will receive.
Every practice sale has unique considerations that require personalized guidance.
Market Activity
Despite the regulations, market activity in Oregon remains strong. Consolidation is the dominant trend, with both large healthcare organizations and private equity firms actively seeking to partner with high-quality nephrology practices. Here is how they typically approach the market.
The Rise of Strategic Buyers
Large dialysis organizations and regional hospital systems are often looking to expand their footprint. For them, acquiring your practice is a way to secure a patient population and specialist talent. These buyers know the clinical side of the business and are often focused on long-term integration into their existing network.
Private Equity’s MSO Model
Private equity (PE) firms see the growth potential in nephrology but cannot directly own a majority of your practice due to CPOM. To solve this, they use a Management Services Organization (MSO) model. The PE-backed MSO acquires your practice’s non-clinical assets and provides all management services for a fee. You and your partners retain majority ownership of the clinical practice itself, satisfying the law while gaining a powerful financial and operational partner.
Sale Process
Selling your practice is a multi-stage process that requires careful management. It begins long before your practice is shown to any buyers. The first step is preparation, where we help you organize your financials and craft the story of your practice to highlight its strengths. Next, we confidentially market your practice to a curated list of qualified buyers. This generates competitive interest, leading to formal offers. Once an offer is accepted, the process moves into due diligence, where the buyer verifies all the information about your practice. This is where many sales encounter unexpected challenges. With proper guidance, this phase leads to a final purchase agreement and a successful closing.
Preparing properly for buyer due diligence can prevent unexpected issues.
Valuation
Determining what your nephrology practice is worth is both an art and a science. Sophisticated buyers don’t look at your revenue. They look at your profitability, specifically a metric called Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). This figure represents your practice’s true cash flow after normalizing for owner-specific expenses. That Adjusted EBITDA is then multiplied by a number the valuation multiple to arrive at your practice’s value. The multiple isn’t random. It is based on the quality and risk of your practice.
| Factors That Increase Your Multiple | Factors That Decrease Your Multiple |
|---|---|
| Multiple licensed providers | High reliance on a single owner |
| Strong history of growth | Flat or declining revenue |
| Participation in value-based care | Purely fee-for-service model |
| Diversified referral sources | Dependence on one hospital |
| Favorable payer contracts | Poorly negotiated insurance rates |
A professional valuation is the only way to truly understand what your practice could be worth in today’s market.
A comprehensive valuation is the foundation of a successful practice transition strategy.
Post-Sale Considerations
The transaction is not the end of the journey. A successful transition plan looks at what happens the day after the deal closes. You need to decide on your future role. Do you want to continue practicing for several years, or are you ready to retire? The terms of this are negotiated upfront. Consideration for your long-term staff is also critical for a smooth handover. Furthermore, your compensation might not be 100% cash at close. Deals often include structured earnouts tied to future performance or the option to retain rollover equity in the new, larger company. This can provide a “second bite of the apple,” giving you a significant financial upside when your new partner eventually sells.
Your specific goals and timeline should drive your practice transition strategy.
Frequently Asked Questions
What are the main market factors affecting the sale of a nephrology practice in Oregon?
The main market factors include a surging patient need for kidney care, a projected 21% shortage of nephrologists by 2037, and a shift towards value-based care models like Kidney Care Choices (KCC). These factors increase the attractiveness and value of nephrology practices in Oregon.
How does Oregon’s Corporate Practice of Medicine (CPOM) law impact the sale of a nephrology practice?
Oregon’s CPOM law requires that at least 51% of a medical practice be owned by Oregon-licensed medical providers. This restricts corporate or private equity groups from owning a majority stake, influencing deal structures and limiting the types of buyers. Compliance with CPOM is essential to avoid legal issues and ensure a successful sale.
Who are the typical buyers interested in purchasing a nephrology practice in Oregon?
Typical buyers include large healthcare organizations such as dialysis providers and hospital systems looking to expand their patient base and specialist network. Private equity firms also participate, usually through a Management Services Organization (MSO) model, where they acquire non-clinical assets and provide management services while the clinical practice owners retain majority ownership.
What determines the valuation of a nephrology practice in Oregon?
Valuation is primarily based on the practice’s profitability measured by Adjusted EBITDA, multiplied by a valuation multiple. Factors that increase the multiple include multiple licensed providers, growth history, value-based care participation, diversified referral sources, and favorable payer contracts. Factors reducing the multiple include reliance on a single owner, flat or declining revenue, fee-for-service models, dependence on one hospital, and poorly negotiated insurance rates.
What should sellers consider after closing the sale of their nephrology practice?
Post-sale considerations include deciding on the seller’s future role in the practice (continuing to practice vs. retirement), ensuring smooth staff transitions, and understanding compensation structures like structured earnouts or rollover equity. These elements should align with the seller’s long-term goals and timeline for a successful transition.